Teva Pharmaceutical Industries Ltd (TEVJF) Receivables (2009 - 2026)

Teva Pharmaceutical Industries' (TEVJF) quarterly Receivables came in at $3.5 billion in Q2 2026, down 1.99% YoY from $3.6 billion in Q2 2025, and up 2.95% on a QoQ basis from $3.4 billion in Q1 2026.

Teva Pharmaceutical Industries Ltd (TEVJF) Receivables (2009 - 2026) Analysis & Trends

Teva Pharmaceutical Industries (TEVJF) has 18 years of Receivables data on file, last reported at $3.5 billion in Q2 2026.

  • Quarterly Receivables fell 1.99% year-over-year to $3.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.5 billion (down 1.99% YoY) and the FY2025 annual result came in at $3.7 billion, up 21.25% from the prior year.
  • Receivables advanced to $3.5 billion in Q2 2026, from $3.4 billion in the prior quarter.
  • In the past five years, Receivables ranged from a high of $4.5 billion in Q2 2022 to a low of $3.1 billion in Q4 2024.
  • A 5-year average of $3.6 billion and a median of $3.5 billion in 2023 frame the typical range for Receivables.
  • Annual changes were most pronounced in 2023 — Receivables decreased 20.85% — and 2025, when it rose 21.25%.
  • Tracing TEVJF's Receivables over 5 years: stood at $3.7 billion in 2022, then retreated by 7.79% to $3.4 billion in 2023, then slipped by 10.24% to $3.1 billion in 2024, then grew by 21.25% to $3.7 billion in 2025, then slipped by 5.82% to $3.5 billion in 2026.
  • The last three Receivables figures came in at $3.5 billion (Q2 2026), $3.4 billion (Q1 2026), and $3.7 billion (Q4 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 3.49 Bn
Mar 31, 2026 3.39 Bn
Dec 31, 2025 3.71 Bn
Sep 30, 2025 3.81 Bn
Jun 30, 2025 3.56 Bn
Mar 31, 2025 3.38 Bn
Dec 31, 2024 3.06 Bn
Sep 30, 2024 3.46 Bn
Jun 30, 2024 3.77 Bn
Mar 31, 2024 3.46 Bn
Dec 31, 2023 3.41 Bn
Sep 30, 2023 3.39 Bn
Jun 30, 2023 3.54 Bn
Mar 31, 2023 3.44 Bn
Dec 31, 2022 3.70 Bn
Sep 30, 2022 3.73 Bn
Jun 30, 2022 4.47 Bn
Mar 31, 2022 4.25 Bn
Dec 31, 2021 4.53 Bn
Sep 30, 2021 4.05 Bn